圧迫療法市場 – 2030年までの世界予測

本市場調査では、圧迫療法市場を製品、技術、用途、流通チャネル、地域別にセグメント化し、分析しています。市場に影響を与える主要な要因（牽引要因、制約要因、機会、課題など）に関する洞察を提供しています。

本レポートでは、ステークホルダーにとっての機会と課題を浮き彫りにし、主要な市場プレーヤーに焦点を当てた競争環境の詳細な分析を提供しています。さらに、マイクロマーケットについてもより詳細に分析し、成長パターン、機会、そして圧迫療法市場全体への貢献について考察しています。また、様々な市場セグメントの収益予測を掲載し、5つの主要地域における成長機会を特定しています。

The compression therapy market is expected to experience significant growth, increasing from USD 4.5 billion in 2025 to USD 5.9 billion by 2030, at a CAGR of 5.5%.

圧迫療法市場は、2025 年の 45 億米ドルから 2030 年には 59 億米ドルに増加し、年平均成長率 5.5% で大幅に成長すると予想されています。

This expansion is driven by several factors, including a growing elderly population, a notable rise in chronic venous insufficiency cases, and an increase in lymphedema related to cancer treatments. Additionally, the prevalence of sedentary lifestyles and rising obesity rates has led to a surge in circulatory disorders, creating a higher demand for non-invasive treatment options.

Improvements in product comfort, the development of discreet wearable designs, and increased clinical awareness among physicians have further contributed to the adoption of compression therapy in outpatient and home settings. These trends, along with wider reimbursement coverage in key markets, continue to bolster global market growth.

“Compression garments dominated the market in 2024.”

Compression garments lead the compression therapy market due to their extensive use in treating conditions like varicose veins, lymphedema, and chronic venous insufficiency. These products, including stockings, sleeves, and wraps, are popular because they are easy to use, available in various compression levels, and suitable for clinical settings and home care. Their increasing importance in post-surgical recovery and preventive care for at-risk populations, such as the elderly and those with sedentary lifestyles, has further driven demand. Additionally, ongoing innovations in product design, including the use of more breathable and comfortable fabrics, support their continued dominance in the market.

“The hospitals & clinics segment held the largest share of the compression therapy market in 2024.”

Hospitals & clinics are the primary distribution channels in the compression therapy market, especially for specialty products such as pneumatic compression devices and advanced therapeutic stockings. These medical facilities play a crucial role in treating conditions like chronic venous insufficiency, lymphedema, and post-surgical recovery. The prescriptions and recommendations made by physicians in clinical settings are vital for driving demand for compression therapy products. The growing clinical acceptance and well-established benefits of compression therapy contribute to its widespread use in these environments. Consequently, hospitals & clinics stand out as the leading distribution channels.

“The Asia Pacific regional segment is expected to register the highest CAGR in the compression therapy market during the forecast period.”

The growth in this market is driven by several factors, including an aging population in Japan and China, where venous and lymphatic issues are becoming more prevalent. Additionally, rising healthcare awareness and improvements in medical infrastructure in emerging economies like India are contributing to the increased use of compression therapy. Economic growth in the region is also elevating disposable incomes, enabling more individuals to access and afford these therapeutic products. Together, these trends, along with a growing acceptance of preventive care and post-surgical treatment, are accelerating market growth in the Asia Pacific (APAC) region.

A breakdown of the primary participants referred to for this report is provided below:

• By Company: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
• By Designation: C-level Executives (35%), Director-level Executives (25%), and Others (40%)
• By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and the Middle East & Africa (5%)

Prominent players in the compression therapy market include 3M (US), BSN Medical (Germany), medi GmbH & Co. KG (Germany), Sigvaris AG (Switzerland), Juzo GmbH (Germany), Lohmann & Rauscher GmbH & Co. KG (Germany), DJO Global (US), JOBST (US), Therafirm (US), Bauerfeind AG (Germany), PAUL HARTMANN AG (Germany), CircAid Medical Products, Inc. (US), Tactile Medical (US), Bio Compression Systems, Inc. (US), THUASNE (France), among others.

Research Coverage

This market research analyzes the compression therapy market by segmenting it according to product, technique, application, distribution channel, and region. It provides insights into key factors influencing the market, including drivers, restraints, opportunities, and challenges. The report highlights opportunities and challenges for stakeholders and offers a detailed analysis of the competitive landscape, focusing on major market players. Additionally, it examines the micromarkets in greater detail, looking at growth patterns, opportunities, and their contributions to the overall compression therapy market. The report also includes revenue generation forecasts for various market segments and identifies growth opportunities across five key regions.

Key Benefits of Buying this Report

This report is valuable for both new and current players in the market, offering essential information to identify potential investment opportunities. It provides a comprehensive overview of both major and minor players, facilitating effective risk analysis and informed investment decisions. The report includes precise segmentation based on end users and geographical regions, offering detailed insights into niche market segments. Additionally, it highlights key trends, challenges, growth drivers, and opportunities, supporting strategic decision-making through a balanced analysis.

Through this report, readers get insightful views into the following parameters:

The compression therapy market is experiencing growth driven by several key factors, including the increasing prevalence of chronic conditions such as venous insufficiency and lymphedema, which require long-term management. Advances in automated diagnostic tools and smart compression devices are enhancing treatment efficiency and accuracy.

However, high product costs and a lack of awareness in emerging markets constrain this growth. However, there are also significant opportunities for the market, such as product innovation in areas like antimicrobials and custom-fit solutions. Market diversification through new product launches and expansions into untapped regions could further propel growth in the compression therapy market.

• Product Development/Innovation: Emerging technologies, ongoing R&D activities, and recent launches of products in the market
• Market Development: The report has elaborated the markets by segmenting the compression therapy market into different regions
• Market Diversification: New product launches, unexploited markets, recent developments, and investments in the compression therapy market
• Competitive Analysis: A comprehensive analysis of market share, product offerings, and leading strategies of major players, such as 3M (US), BSN Medical (Germany), medi GmbH & Co. KG (Germany), Sigvaris AG (Switzerland), Juzo GmbH (Germany), Lohmann & Rauscher GmbH & Co. KG (Germany), DJO Global (US), JOBST (US), Therafirm (US), Bauerfeind AG (Germany), PAUL HARTMANN AG (Germany), CircAid Medical Products, Inc. (US), Tactile Medical (US), Bio Compression Systems, Inc. (US), and THUASNE (France)

Table of Contents

1               INTRODUCTION              25

1.1           STUDY OBJECTIVES       25

1.2           MARKET DEFINITION   25

1.3           STUDY SCOPE   26

1.3.1        MARKETS COVERED & REGIONAL SCOPE             26

1.3.2        INCLUSIONS & EXCLUSIONS       27

1.3.3        YEARS CONSIDERED      27

1.4           CURRENCY CONSIDERED            28

1.5           STAKEHOLDERS               28

1.6           SUMMARY OF CHANGES               29

2               RESEARCH METHODOLOGY       30

2.1           RESEARCH DATA              30

2.1.1        SECONDARY RESEARCH                31

2.1.1.1    Key secondary sources         31

2.1.1.2    Key data from secondary sources       32

2.1.1.3    Objectives of secondary research       32

2.1.2        PRIMARY RESEARCH       33

2.1.2.1    Key primary sources (demand and supply sides)            33

2.1.2.2    Supply- and demand-side participants              34

2.1.2.3    Breakdown of primary interviews: By company type, designation, and region              34

2.1.2.4    Objectives of primary research           34

2.1.2.5    Insights from industry experts            35

2.2           MARKET SIZE ESTIMATION         35

2.2.1        BOTTOM-UP APPROACH              37

2.2.1.1    Approach 1: Company revenue estimation       37

2.2.1.2    Approach 2: Customer-based market estimation             38

2.2.1.3    Approach 3: Primary interviews         39

2.2.2        BOTTOM-UP APPROACH              39

2.3           GROWTH RATE ASSUMPTIONS 40

2.4           DATA TRIANGULATION                42

2.5           RESEARCH ASSUMPTIONS           43

2.6           RESEARCH LIMITATIONS             43

2.7           RISK ASSESSMENT           43

3               EXECUTIVE SUMMARY  44

4               PREMIUM INSIGHTS       48

4.1           ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN COMPRESSION THERAPY MARKET          48

4.2           COMPRESSION THERAPY MARKET, BY REGION 49

4.3           NORTH AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY AND

DISTRIBUTION CHANNEL            50

4.4           COMPRESSION THERAPY MARKET: GEOGRAPHIC SNAPSHOT          51

5               MARKET OVERVIEW       52

5.1           INTRODUCTION              52

5.2           MARKET DYNAMICS       52

5.2.1        DRIVERS               53

5.2.1.1    Large target patient population          53

5.2.1.2    Growing incidence of sports injuries and accidents        54

5.2.1.3    Increasing number of orthopedic procedures  55

5.2.1.4    Greater product affordability and market availability     55

5.2.1.5    Clinical evidence favoring adoption of compression therapy for management of target conditions      56

5.2.2        RESTRAINTS      56

5.2.2.1    Lack of universally accepted standards for compression products                 56

5.2.2.2    Low patient compliance with compression garments     57

5.2.3        OPPORTUNITIES              57

5.2.3.1    Growth potential offered by emerging markets               57

5.2.3.2    Growing patient awareness regarding benefits of compression therapy   58

5.2.4        CHALLENGES    58

5.2.4.1    Significant adoption of alternative therapies for specific target indications             58

5.2.4.2    Increasing pricing pressure on market players 59

5.3           PORTER’S FIVE FORCES ANALYSIS           60

5.3.1        THREAT OF NEW ENTRANTS      61

5.3.2        THREAT OF SUBSTITUTES          61

5.3.3        BARGAINING POWER OF SUPPLIERS       61

5.3.4        BARGAINING POWER OF BUYERS             61

5.3.5        INTENSITY OF COMPETITIVE RIVALRY 61

5.4           REGULATORY ANALYSIS               62

5.4.1        REGULATORY ANALYSIS               62

5.4.1.1    US           62

5.4.1.2    Canada   63

5.4.1.3    Europe   63

5.4.1.4    Japan      64

5.4.2        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             64

5.5           REIMBURSEMENT SCENARIO     66

5.6           ECOSYSTEM ANALYSIS  67

5.7           INVESTMENT & FUNDING SCENARIO     68

5.8           TECHNOLOGY ANALYSIS             69

5.8.1        KEY TECHNOLOGIES     69

5.8.1.1    Pneumatic compression devices         69

5.8.1.2    Smart compression garments              69

5.8.1.3    Static compression devices 70

5.8.2        COMPLEMENTARY TECHNOLOGIES       70

5.8.2.1    Digital connectivity (telehealth platforms)      70

5.8.2.2    Value-added software (AI & IOT)    70

5.8.3        ADJACENT TECHNOLOGIES       70

5.8.3.1    Custom-fitted compression garments                70

5.9           VALUE CHAIN ANALYSIS               71

5.9.1        RESEARCH & DEVELOPMENT    71

5.9.2        RAW MATERIAL PROCUREMENT & PRODUCT MANUFACTURING          71

5.9.3        DISTRIBUTION, MARKETING & SALES, AND AFTER-SALES SERVICES               71

5.10         SUPPLY CHAIN ANALYSIS             72

5.10.1      PROMINENT COMPANIES            72

5.10.2      SMALL AND MEDIUM-SIZED ENTERPRISES          73

5.10.3      END USERS         73

5.11         PRICING ANALYSIS          73

5.11.1      AVERAGE SELLING PRICE TREND, BY PRODUCT TYPE                 74

5.11.2      AVERAGE SELLING PRICE TREND OF COMPRESSION THERAPY DEVICES,

BY PRODUCT TYPE, 2022–2024    75

5.11.3      AVERAGE SELLING PRICE TREND OF COMPRESSION STOCKINGS,

BY KEY PLAYER, 2022–2024            75

5.11.4      AVERAGE SELLING PRICE OF COMPRESSION STOCKINGS, BY KEY PLAYER, 2022–2024 76

5.11.5      AVERAGE SELLING PRICE TREND OF COMPRESSION BRACES,

BY KEY PLAYER, 2022–2024          76

5.11.6      AVERAGE SELLING PRICE OF COMPRESSION BRACES, BY KEY PLAYER, 2022–2024            76

5.11.7      AVERAGE SELLING PRICE TREND OF COMPRESSION THERAPY PRODUCTS,

BY REGION, 2022–2024    77

5.11.8      AVERAGE SELLING PRICE OF COMPRESSION THERAPY PRODUCTS,

BY REGION, 2022–2024    77

5.12         PATENT ANALYSIS          79

5.13         TRADE ANALYSIS             80

5.13.1      IMPORT SCENARIO (HS CODE 611510)    80

5.13.2      EXPORT SCENARIO (HS CODE 611510)    81

5.14         KEY CONFERENCES & EVENTS, 2025–2026              82

5.15         TRENDS & DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       83

5.16         KEY STAKEHOLDERS & BUYING CRITERIA            83

5.16.1      KEY STAKEHOLDERS IN BUYING PROCESS           83

5.16.2      BUYING CRITERIA           85

5.17         UNMET NEEDS & KEY PAIN POINTS        86

5.18         IMPACT OF AI ON COMPRESSION THERAPY MARKET                 87

5.19         IMPACT OF 2025 US TARIFF ON COMPRESSION THERAPY MARKET          87

5.19.1      INTRODUCTION              87

5.19.2      KEY TARIFF RATES          88

5.19.3      PRICE IMPACT ANALYSIS             88

5.19.4      IMPACT ON COUNTRY/REGION                89

5.19.4.1  US           89

5.19.4.2  Europe   89

5.19.4.3  Asia Pacific            90

5.19.5      IMPACT ON END-USE INDUSTRIES          90

6               COMPRESSION THERAPY MARKET, BY PRODUCT                 91

6.1           INTRODUCTION              92

6.2           COMPRESSION BANDAGES         92

6.2.1        LIMITED AVAILABILITY OF MEDICAL REIMBURSEMENTS FOR VARICOSE VEIN SURGERIES TO RESTRAIN MARKET GROWTH    92

6.3           COMPRESSION WRAPS  97

6.3.1        RISING GERIATRIC POPULATION AND INCREASING INCIDENCE OF SPORTS INJURIES TO DRIVE MARKET     97

6.4           COMPRESSION STOCKINGS        102

6.4.1        CLASS I COMPRESSION STOCKINGS        107

6.4.1.1    Advantages such as comfort and durability to drive demand for Class I stockings   107

6.4.2        CLASS II COMPRESSION STOCKINGS      107

6.4.2.1    Increasing number of lymphedema and DVT patients to fuel demand  107

6.4.3        CLASS III COMPRESSION STOCKINGS     108

6.4.3.1    High level of compression provided to boost adoption of Class III stockings                108

6.5           COMPRESSION TAPES   109

6.5.1        ABILITY TO PREVENT FURTHER MUSCLE INJURY TO DRIVE DEMAND FOR COMPRESSION TAPES        109

6.6           PNEUMATIC COMPRESSION DEVICES    114

6.6.1        INTERMITTENT COMPRESSION DEVICES             120

6.6.1.1    Availability of wide range of intermittent pumps with varying designs and complexity to boost demand         120

6.6.2        SEQUENTIAL COMPRESSION DEVICES  120

6.6.2.1    Wide usage for DVT prevention to boost growth            120

6.7           COMPRESSION BRACES 121

6.7.1        RISING NUMBER OF JOINT REPLACEMENT SURGERIES TO SUPPORT MARKET  121

6.8           OTHER COMPRESSION GARMENTS         126

7               COMPRESSION THERAPY MARKET, BY TECHNIQUE                 130

7.1           INTRODUCTION              131

7.2           STATIC COMPRESSION THERAPY             131

7.2.1        PROCEDURAL ADVANTAGES OF STATIC COMPRESSION THERAPY TO DRIVE GROWTH   131

7.3           DYNAMIC COMPRESSION THERAPY        132

7.3.1        RISING INCIDENCE OF TARGET CONDITIONS TO SUPPORT MARKET          132

8               COMPRESSION THERAPY MARKET, BY APPLICATION                 134

8.1           INTRODUCTION              135

8.2           VARICOSE VEIN TREATMENT     135

8.2.1        GROWING GLOBAL PREVALENCE OF VARICOSE VEINS TO DRIVE MARKET         135

8.3           DEEP VEIN THROMBOSIS TREATMENT 136

8.3.1        AVAILABILITY OF ALTERNATIVE TREATMENTS FOR DVT TO LIMIT GROWTH               136

8.4           LYMPHEDEMA TREATMENT       137

8.4.1        RISING INCIDENCE OF CANCER TO CONTRIBUTE TO GROWTH             137

8.5           LEG ULCER TREATMENT              138

8.5.1        GROWING DISEASE BURDEN ACROSS MAJOR COUNTRIES TO BOOST MARKET              138

8.6           OTHER APPLICATIONS 139

9               COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL            141

9.1           INTRODUCTION              142

9.2           PHARMACIES & RETAILERS         142

9.2.1        RISING ADOPTION OF OFF-THE-SHELF PRODUCTS TO SUPPORT MARKET GROWTH     142

9.3           E-COMMERCE PLATFORMS         143

9.3.1        E-COMMERCE PLATFORMS TO REGISTER HIGH CAGR DURING FORECAST PERIOD       143

9.4           HOSPITALS & CLINICS   144

9.4.1        HEALTHCARE INFRASTRUCTURAL IMPROVEMENTS TO BOOST GROWTH             144

9.5           HOME CARE SETTINGS 145

9.5.1        GROWING INCLINATION TOWARD HOME HEALTHCARE TO DRIVE MARKET            145

10            COMPRESSION THERAPY MARKET, BY REGION 147

10.1         INTRODUCTION              148

10.2         NORTH AMERICA             148

10.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 149

10.2.2      US           153

10.2.2.1  Rising number of sports injuries to drive market growth                 153

10.2.3      CANADA               155

10.2.3.1  Increasing incidence of target diseases to support growth                 155

10.3         EUROPE               156

10.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      157

10.3.2      GERMANY           160

10.3.2.1  Inconsistent reimbursement for compression therapy products to restrain market growth        160

10.3.3      FRANCE                162

10.3.3.1  High incidence of diabetes to drive demand for compression therapy   162

10.3.4      UK          163

10.3.4.1  Rising prevalence of lymphedema and DVT to drive market                 163

10.3.5      ITALY    165

10.3.5.1  Rising awareness about preventive care for musculoskeletal injuries to fuel growth          165

10.3.6      SPAIN    166

10.3.6.1  Growing presence of key manufacturers to increase access to compression therapy products            166

10.3.7      REST OF EUROPE             167

10.4         ASIA PACIFIC     169

10.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 169

10.4.2      CHINA  174

10.4.2.1  Modernization of healthcare facilities to drive market growth                 174

10.4.3      JAPAN   175

10.4.3.1  Japan to dominate Asia Pacific compression therapy market                 175

10.4.4      INDIA    177

10.4.4.1  Growing number of hip & knee surgeries to support market                 177

10.4.5      AUSTRALIA         179

10.4.5.1  Government subsidies related to compression garments for lymphedema patients to promote growth         179

10.4.6      SOUTH KOREA  180

10.4.6.1  Increasing number of plastic surgeries to drive demand for compression garments         180

10.4.7      REST OF ASIA PACIFIC   182

10.5         LATIN AMERICA                183

10.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 183

10.5.2      BRAZIL 186

10.5.2.1  Rising number of cosmetic surgeries to support market                 186

10.5.3      MEXICO                188

10.5.3.1  Lack of reimbursement for bracing products to limit growth                 188

10.5.4      REST OF LATIN AMERICA             189

10.6         MIDDLE EAST & AFRICA                190

10.6.1      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 191

10.6.2      GCC COUNTRIES              194

10.6.2.1  Significant investments in healthcare to boost growth   194

10.6.3      REST OF MIDDLE EAST & AFRICA             195

11            COMPETITIVE LANDSCAPE         196

11.1         INTRODUCTION              196

11.2         KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2024                 196

11.3         REVENUE ANALYSIS, 2020–2024  198

11.4         MARKET SHARE ANALYSIS, 2024                 199

11.4.1      COMPRESSION STOCKINGS MARKET SHARE       199

11.4.2      COMPRESSION BANDAGES MARKET SHARE        200

11.4.3      PNEUMATIC COMPRESSION DEVICES MARKET SHARE                 200

11.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024                 203

11.5.1      STARS   203

11.5.2      EMERGING LEADERS     203

11.5.3      PERVASIVE PLAYERS      204

11.5.4      PARTICIPANTS 204

11.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2024         205

11.5.5.1  Company footprint               205

11.5.5.2  Region footprint   206

11.5.5.3  Product footprint  206

11.5.5.4  Application footprint            207

11.5.5.5  Technique footprint             208

11.5.5.6  Distribution channel footprint            209

11.6         COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024        210

11.6.1      PROGRESSIVE COMPANIES         210

11.6.2      RESPONSIVE COMPANIES            210

11.6.3      DYNAMIC COMPANIES  210

11.6.4      STARTING BLOCKS         210

11.6.5      COMPANY BENCHMARKING: START-UPS/SMES, 2024                 212

11.6.5.1  List of start-ups/SMEs        212

11.6.5.2  Competitive benchmarking of start-ups/SMEs               213

11.7         COMPANY VALUATION & FINANCIAL METRICS 214

11.8         PRODUCT/BRAND COMPARISON             215

11.9         COMPETITIVE SCENARIO             216

11.9.1      PRODUCT LAUNCHES & APPROVALS     216

11.9.2      DEALS  217

12            COMPANY PROFILES      219

12.1         KEY PLAYERS     219

12.1.1      SOLVENTUM CORPORATION (3M)           219

12.1.1.1  Business overview 219

12.1.1.2  Products offered   220

12.1.1.3  Recent developments           222

12.1.1.3.1                Product launches & approvals            222

12.1.1.3.2                Deals      222

12.1.1.4  MnM view              222

12.1.1.4.1                Key strengths        222

12.1.1.4.2                Strategic choices   223

12.1.1.4.3                Weaknesses & competitive threats     223

12.1.2      ENOVIS CORPORATION                224

12.1.2.1  Business overview 224

12.1.2.2  Products offered   225

12.1.2.3  Recent developments           226

12.1.2.3.1                Product launches  226

12.1.2.3.2                Deals      226

12.1.2.4  MnM view              227

12.1.2.4.1                Key strengths        227

12.1.2.4.2                Strategic choices   227

12.1.2.4.3                Weaknesses & competitive threats     227

12.1.3      BSN MEDICAL (A SUBSIDIARY OF ESSITY)            228

12.1.3.1  Business overview 228

12.1.3.2  Products offered   229

12.1.3.3  Recent developments           230

12.1.3.3.1                Deals      230

12.1.3.4  MnM view              230

12.1.3.4.1                Key strengths        230

12.1.3.4.2                Strategic choices   230

12.1.3.4.3                Weaknesses & competitive threats     231

12.1.4      CARDINAL HEALTH        232

12.1.4.1  Business overview 232

12.1.4.2  Products offered   233

12.1.4.3  Recent developments           234

12.1.4.3.1                Product launches & approvals            234

12.1.4.4  MnM view              234

12.1.4.4.1                Key strengths        234

12.1.4.4.2                Strategic choices   234

12.1.4.4.3                Weaknesses & competitive threats     235

12.1.5      ARJOHUNTLEIGH            236

12.1.5.1  Business overview 236

12.1.5.2  Products offered   237

12.1.5.3  MnM view              238

12.1.5.3.1                Key strengths        238

12.1.5.3.2                Strategic choices   238

12.1.5.3.3                Weaknesses & competitive threats     238

12.1.6      TACTILE MEDICAL          239

12.1.6.1  Business overview 239

12.1.6.2  Products offered   240

12.1.6.3  Recent developments           240

12.1.6.3.1                Product launches  240

12.1.7      CONVATEC INC.               241

12.1.7.1  Business overview 241

12.1.7.2  Products offered   242

12.1.7.3  Recent developments           243

12.1.7.3.1                Deals      243

12.1.8      BIO COMPRESSION SYSTEMS, INC.           244

12.1.8.1  Business overview 244

12.1.8.2  Products offered   244

12.1.9      JUZO GMBH        245

12.1.9.1  Business overview 245

12.1.9.2  Products offered   245

12.1.9.3  Recent developments           246

12.1.9.3.1                Product launches  246

12.1.10   MEDI GMBH & CO. KG   247

12.1.10.1                 Business overview 247

12.1.10.2                 Products offered   247

12.1.11   PAUL HARTMANN            249

12.1.11.1                 Business overview 249

12.1.11.2                 Products offered   250

12.1.11.3                 Recent developments           251

12.1.11.3.1             Deals      251

12.1.12   SANYLEG, S.R.L.                 252

12.1.12.1                 Business overview 252

12.1.12.2                 Products offered   252

12.1.13   SIGVARIS GROUP             254

12.1.13.1                 Business overview 254

12.1.13.2                 Products offered   254

12.1.13.3                 Recent developments           255

12.1.13.3.1             Deals      255

12.1.14   SMITH+NEPHEW              256

12.1.14.1                 Business overview 256

12.1.14.2                 Products offered   257

12.1.14.3                 Recent developments           258

12.1.14.3.1             Expansions             258

12.1.15   MEGO AFEK, LTD.            259

12.1.15.1                 Business overview 259

12.1.15.2                 Products offered   259

12.2         OTHER PLAYERS              261

12.2.1      GOTTFRIED MEDICAL, INC.        261

12.2.2      THERMOTEK, INC.           262

12.2.3      BAUERFEIND AG              263

12.2.4      OFA BAMBERG GMBH    264

12.2.5      MEDLINE INDUSTRIES  265

12.2.6      ACI MEDICAL    266

12.2.7      AIROS MEDICAL INC.     267

12.2.8      BARCELCOM TÊXTEIS, S.A           268

12.2.9      CIZETA MEDICALI S.P.A                269

12.2.10   BÖSL MEDIZINTECHNIK               270

13            APPENDIX           271

13.1         DISCUSSION GUIDE        271

13.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                275

13.3         CUSTOMIZATION OPTIONS        277

13.4         RELATED REPORTS         277

13.5         AUTHOR DETAILS           278

LIST OF TABLES

TABLE 1                STANDARD CURRENCY CONVERSION RATES                 28

TABLE 2                PORTER’S FIVE FORCES ANALYSIS           60

TABLE 3                NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 64

TABLE 4                EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           64

TABLE 5                ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 65

TABLE 6                LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 65

TABLE 7                MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 66

TABLE 8                REIMBURSEMENT CODES FOR VARIOUS PROCEDURES    66

TABLE 9                AVERAGE SELLING PRICE OF COMPRESSION STOCKINGS, BY KEY PLAYER,

2022–2024 (USD)                76

TABLE 10              AVERAGE SELLING PRICE OF COMPRESSION BRACES, BY KEY PLAYER,

2022–2024 (USD)                76

TABLE 11              AVERAGE SELLING PRICE OF COMPRESSION THERAPY PRODUCT TYPE, BY REGION, 2022–2024             77

TABLE 12              COMPRESSION THERAPY MARKET: LIST OF MAJOR PATENTS              80

TABLE 13              IMPORT DATA FOR HS CODE 611510, BY COUNTRY,

2020–2024 (USD THOUSAND)      81

TABLE 14              EXPORT DATA FOR HS CODE 611510, BY COUNTRY,

2020–2024 (USD THOUSAND)      82

TABLE 15              COMPRESSION THERAPY MARKET: KEY CONFERENCES & EVENTS, 2025–2026       82

TABLE 16              KEY REQUIREMENTS OF STAKEHOLDERS WHILE BUYING COMPRESSION

THERAPY PRODUCTS    84

TABLE 17              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF COMPRESSION

THERAPY PRODUCTS (%)            85

TABLE 18              UNMET CUSTOMER NEEDS & KEY PAIN POINTS                 86

TABLE 19              US-ADJUSTED RECIPROCAL TARIFF RATES                 88

TABLE 20              COMPRESSION THERAPY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     92

TABLE 21              COMPRESSION BANDAGES MARKET, BY REGION, 2023–2030 (USD MILLION)          93

TABLE 22              NORTH AMERICA: COMPRESSION BANDAGES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            93

TABLE 23              EUROPE: COMPRESSION BANDAGES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            94

TABLE 24              ASIA PACIFIC: COMPRESSION BANDAGES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            94

TABLE 25              LATIN AMERICA: COMPRESSION BANDAGES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            95

TABLE 26              MIDDLE EAST & AFRICA: COMPRESSION BANDAGES MARKET, BY REGION,

2023–2030 (USD MILLION)            95

TABLE 27              COMPRESSION BANDAGES MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 95

TABLE 28              COMPRESSION BANDAGES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              96

TABLE 29              COMPRESSION BANDAGES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            96

TABLE 30              COMPRESSION WRAPS MARKET, BY REGION, 2023–2030 (USD MILLION)            97

TABLE 31              NORTH AMERICA: COMPRESSION WRAPS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            98

TABLE 32              EUROPE: COMPRESSION WRAPS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            98

TABLE 33              ASIA PACIFIC: COMPRESSION WRAPS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            99

TABLE 34              LATIN AMERICA: COMPRESSION WRAPS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            99

TABLE 35              MIDDLE EAST & AFRICA: COMPRESSION WRAPS MARKET, BY REGION,

2023–2030 (USD MILLION)            100

TABLE 36              COMPRESSION WRAPS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 100

TABLE 37              COMPRESSION WRAPS MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              101

TABLE 38              COMPRESSION WRAPS MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            101

TABLE 39              COMPRESSION STOCKINGS MARKET, BY TYPE, 2023–2030 (USD MILLION)            102

TABLE 40              COMPRESSION STOCKINGS MARKET, BY REGION, 2023–2030 (USD MILLION)          103

TABLE 41              NORTH AMERICA: COMPRESSION STOCKINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            103

TABLE 42              EUROPE: COMPRESSION STOCKINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            104

TABLE 43              ASIA PACIFIC: COMPRESSION STOCKINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            104

TABLE 44              LATIN AMERICA: COMPRESSION STOCKINGS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            105

TABLE 45              MIDDLE EAST & AFRICA: COMPRESSION STOCKINGS MARKET, BY REGION,

2023–2030 (USD MILLION)            105

TABLE 46              COMPRESSION STOCKINGS MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 105

TABLE 47              COMPRESSION STOCKINGS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            106

TABLE 48              COMPRESSION STOCKINGS MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            106

TABLE 49              CLASS I COMPRESSION STOCKINGS MARKET, BY REGION,

2023–2030 (USD MILLION)            107

TABLE 50              CLASS II COMPRESSION STOCKINGS MARKET, BY REGION,

2023–2030 (USD MILLION)            108

TABLE 51              CLASS III COMPRESSION STOCKINGS MARKET, BY REGION,

2023–2030 (USD MILLION)            109

TABLE 52              COMPRESSION TAPES MARKET, BY REGION, 2023–2030 (USD MILLION)            109

TABLE 53              NORTH AMERICA: COMPRESSION TAPES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            110

TABLE 54              EUROPE: COMPRESSION TAPES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            110

TABLE 55              ASIA PACIFIC: COMPRESSION TAPES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            111

TABLE 56              LATIN AMERICA: COMPRESSION TAPES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            111

TABLE 57              MIDDLE EAST & AFRICA: COMPRESSION TAPES MARKET, BY REGION,

2023–2030 (USD MILLION)            112

TABLE 58             COMPRESSION TAPES MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)            112

TABLE 59              COMPRESSION TAPES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              113

TABLE 60              COMPRESSION TAPES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            113

TABLE 61              PNEUMATIC COMPRESSION DEVICES MARKET, BY TYPE,

2023–2030 (USD MILLION)            115

TABLE 62              PNEUMATIC COMPRESSION DEVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            115

TABLE 63              NORTH AMERICA: PNEUMATIC COMPRESSION DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 116

TABLE 64              EUROPE: PNEUMATIC COMPRESSION DEVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            116

TABLE 65              ASIA PACIFIC: PNEUMATIC COMPRESSION DEVICES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            117

TABLE 66              LATIN AMERICA: PNEUMATIC COMPRESSION DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 117

TABLE 67              MIDDLE EAST & AFRICA: PNEUMATIC COMPRESSION DEVICES MARKET,

BY REGION, 2023–2030 (USD MILLION)   118

TABLE 68              PNEUMATIC COMPRESSION DEVICES MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            118

TABLE 69              PNEUMATIC COMPRESSION DEVICES MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            119

TABLE 70              PNEUMATIC COMPRESSION DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION)                 119

TABLE 71              INTERMITTENT COMPRESSION DEVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            120

TABLE 72              SEQUENTIAL COMPRESSION DEVICES MARKET, BY REGION,

2023–2030 (USD MILLION)            121

TABLE 73              COMPRESSION BRACES MARKET, BY REGION, 2023–2030 (USD MILLION)            122

TABLE 74              NORTH AMERICA: COMPRESSION BRACES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            122

TABLE 75              EUROPE: COMPRESSION BRACES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            123

TABLE 76              ASIA PACIFIC:COMPRESSION BRACES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            123

TABLE 77              LATIN AMERICA: COMPRESSION BRACES MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            124

TABLE 78              MIDDLE EAST & AFRICA: COMPRESSION BRACES, BY REGION,

2023–2030 (USD MILLION)            124

TABLE 79              COMPRESSION BRACES MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 124

TABLE 80              COMPRESSION BRACES MARKET, BY APPLICATION, 2023–2030 (USD MILLION)              125

TABLE 81              COMPRESSION BRACES MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            125

TABLE 82              OTHER COMPRESSION GARMENTS MARKET, BY REGION,

2023–2030 (USD MILLION)            126

TABLE 83              NORTH AMERICA: OTHER COMPRESSION GARMENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION)                 126

TABLE 84              EUROPE: OTHER COMPRESSION GARMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            127

TABLE 85              ASIA PACIFIC: OTHER COMPRESSION GARMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            127

TABLE 86              LATIN AMERICA: OTHER COMPRESSION GARMENTS MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            128

TABLE 87              MIDDLE EAST & AFRICA: OTHER COMPRESSION GARMENTS MARKET, BY REGION, 2023–2030 (USD MILLION)                 128

TABLE 88              OTHER COMPRESSION GARMENTS MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            128

TABLE 89              OTHER COMPRESSION GARMENTS MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            129

TABLE 90              OTHER COMPRESSION GARMENTS MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            129

TABLE 91              COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION) 131

TABLE 92              STATIC COMPRESSION THERAPY MARKET, BY REGION,

2023–2030 (USD MILLION)            132

TABLE 93              DYNAMIC COMPRESSION THERAPY MARKET, BY REGION,

2023–2030 (USD MILLION)            133

TABLE 94              COMPRESSION THERAPY MARKET, BY APPLICATION, 2023–2030(USD MILLION)               135

TABLE 95              COMPRESSION THERAPY MARKET FOR VARICOSE VEIN TREATMENT, BY REGION, 2023–2030 (USD MILLION)            136

TABLE 96              COMPRESSION THERAPY MARKET FOR DEEP VEIN THROMBOSIS TREATMENT,

BY REGION, 2023–2030 (USD MILLION)   137

TABLE 97              COMPRESSION THERAPY MARKET FOR LYMPHEDEMA TREATMENT, BY REGION, 2023–2030 (USD MILLION)            138

TABLE 98              COMPRESSION THERAPY MARKET FOR LEG ULCER TREATMENT, BY REGION, 2023–2030 (USD MILLION)                 139

TABLE 99              COMPRESSION THERAPY MARKET FOR OTHER APPLICATIONS, BY REGION,

2023–2030 (USD MILLION)            140

TABLE 100            COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            142

TABLE 101            COMPRESSION THERAPY MARKET FOR PHARMACIES & RETAILERS, BY REGION, 2023–2030 (USD MILLION)            143

TABLE 102            COMPRESSION THERAPY MARKET FOR E-COMMERCE PLATFORMS, BY REGION, 2023–2030 (USD MILLION)            144

TABLE 103            COMPRESSION THERAPY MARKET FOR HOSPITALS & CLINICS, BY REGION,

2023–2030 (USD MILLION)            145

TABLE 104            COMPRESSION THERAPY MARKET FOR HOME CARE SETTINGS, BY REGION,

2023–2030 (USD MILLION)            146

TABLE 105            COMPRESSION THERAPY MARKET, BY REGION, 2023–2030 (USD MILLION)            148

TABLE 106            NORTH AMERICA: MACROECONOMIC INDICATORS      149

TABLE 107            NORTH AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            151

TABLE 108            NORTH AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            151

TABLE 109            NORTH AMERICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            152

TABLE 110            NORTH AMERICA: COMPRESSION THERAPY MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            152

TABLE 111            NORTH AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION)            153

TABLE 112            US: KEY MACROINDICATORS     154

TABLE 113            US: COMPRESSION THERAPY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     154

TABLE 114            CANADA: KEY MACROINDICATORS         155

TABLE 115            CANADA: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            156

TABLE 116            EUROPE: MACROECONOMIC INDICATORS                 157

TABLE 117            EUROPE: COMPRESSION THERAPY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            158

TABLE 118            EUROPE: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            158

TABLE 119            EUROPE: COMPRESSION THERAPY MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            159

TABLE 120            EUROPE: COMPRESSION THERAPY MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            159

TABLE 121            EUROPE: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL,

2023–2030 (USD MILLION)            160

TABLE 122            GERMANY: KEY MACROINDICATORS      161

TABLE 123            GERMANY: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            161

TABLE 124            FRANCE: KEY MACROINDICATORS          162

TABLE 125            FRANCE: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            163

TABLE 126            UK: KEY MACROINDICATORS     164

TABLE 127            UK: COMPRESSION THERAPY MARKET, BY PRODUCT, 2023–2030 (USD MILLION)     164

TABLE 128            ITALY: KEY MACROINDICATORS               165

TABLE 129            ITALY: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            166

TABLE 130            SPAIN: KEY MACROINDICATORS               167

TABLE 131            SPAIN: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            167

TABLE 132            HIP SURGERY PROCEDURES (TOTAL PATIENTS) IN EUROPEAN COUNTRIES          168

TABLE 133            REST OF EUROPE: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            168

TABLE 134            ASIA PACIFIC: MACROECONOMIC INDICATORS                 170

TABLE 135            ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            172

TABLE 136            ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            172

TABLE 137            ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            173

TABLE 138            ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            173

TABLE 139            ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION)            174

TABLE 140            CHINA: KEY MACROINDICATORS             175

TABLE 141            CHINA: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            175

TABLE 142            JAPAN: KEY MACROINDICATORS              176

TABLE 143            JAPAN: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            177

TABLE 144            INDIA: KEY MACROINDICATORS               178

TABLE 145            INDIA: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            178

TABLE 146            AUSTRALIA: KEY MACROINDICATORS   179

TABLE 147            AUSTRALIA: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            180

TABLE 148            SOUTH KOREA: KEY MACROINDICATORS                 181

TABLE 149            SOUTH KOREA: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            181

TABLE 150            REST OF ASIA PACIFIC: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            182

TABLE 151            LATIN AMERICA: MACROECONOMIC INDICATORS      183

TABLE 152            LATIN AMERICA: COMPRESSION THERAPY MARKET, BY COUNTRY,

2023–2030 (USD MILLION)            184

TABLE 153            LATIN AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            184

TABLE 154            LATIN AMERICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE,

2023–2030 (USD MILLION)            185

TABLE 155            LATIN AMERICA: COMPRESSION THERAPY MARKET, BY APPLICATION,

2023–2030 (USD MILLION)            185

TABLE 156            LATIN AMERICA: COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION)            186

TABLE 157            BRAZIL: KEY MACROINDICATORS            187

TABLE 158            BRAZIL: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            187

TABLE 159            MEXICO: KEY MACROINDICATORS          188

TABLE 160            MEXICO: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            189

TABLE 161            REST OF LATIN AMERICA: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            190

TABLE 162            MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS      191

TABLE 163            MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY REGION,

2023–2030 (USD MILLION)            191

TABLE 164            MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            192

TABLE 165            MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2023–2030 (USD MILLION)                 192

TABLE 166            MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY APPLICATION, 2023–2030 (USD MILLION)                 193

TABLE 167            MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET,

BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION)                 193

TABLE 168            GCC COUNTRIES: COMPRESSION THERAPY MARKET, BY PRODUCT,

2023–2030 (USD MILLION)            194

TABLE 169            REST OF MIDDLE EAST & AFRICA: COMPRESSION THERAPY MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 195

TABLE 170            OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN

COMPRESSION THERAPY MARKET          197

TABLE 171            COMPRESSION THERAPY MARKET: DEGREE OF COMPETITION 202

TABLE 172            COMPRESSION THERAPY MARKET: REGION FOOTPRINT       206

TABLE 173            COMPRESSION THERAPY MARKET: PRODUCT FOOTPRINT       206

TABLE 174            COMPRESSION THERAPY MARKET: APPLICATION FOOTPRINT         207

TABLE 175            COMPRESSION THERAPY MARKET: TECHNIQUE FOOTPRINT       208

TABLE 176            COMPRESSION THERAPY MARKET: DISTRIBUTION CHANNEL FOOTPRINT 209

TABLE 177            LIST OF KEY START-UPS/SMES  212

TABLE 178            COMPETITIVE BENCHMARKING OF START-UPS/SMES           213

TABLE 179            COMPRESSION THERAPY MARKET: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2021–APRIL 2025            216

TABLE 180            COMPRESSION THERAPY MARKET: DEALS, JANUARY 2021–APRIL 2025            217

TABLE 181            SOLVENTUM CORPORATION: COMPANY OVERVIEW          219

TABLE 182            SOLVENTUM CORPORATION (3M): PRODUCTS OFFERED             220

TABLE 183            SOLVENTUM CORPORATION (3M): PRODUCT LAUNCHES & APPROVALS,

JANUARY 2021–APRIL 2025            222

TABLE 184            SOLVENTUM CORPORATION (3M): DEALS, JANUARY 2021–APRIL 2025            222

TABLE 185            ENOVIS CORPORATION: COMPANY OVERVIEW                 224

TABLE 186            ENOVIS CORPORATION: PRODUCTS OFFERED                 225

TABLE 187            ENOVIS CORPORATION: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025            226

TABLE 188            ENOVIS CORPORATION: DEALS, JANUARY 2021–APRIL 2025           226

TABLE 189            ESSITY: COMPANY OVERVIEW   228

TABLE 190            ESSITY: PRODUCTS OFFERED    229

TABLE 191            ESSITY: DEALS, JANUARY 2021–APRIL 2025                 230

TABLE 192            CARDINAL HEALTH: COMPANY OVERVIEW                 232

TABLE 193            CARDINAL HEALTH: PRODUCTS OFFERED                 233

TABLE 194            CARDINAL HEALTH: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2021–APRIL 2025            234

TABLE 195            ARJOHUNTLEIGH: COMPANY OVERVIEW                 236

TABLE 196            ARJOHUNTLEIGH: PRODUCTS OFFERED                 237

TABLE 197            TACTILE MEDICAL: COMPANY OVERVIEW                 239

TABLE 198            TACTILE MEDICAL: PRODUCTS OFFERED                 240

TABLE 199            TACTILE MEDICAL: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025            240

TABLE 200            CONVATEC INC.: COMPANY OVERVIEW                 241

TABLE 201            CONVATEC INC.: PRODUCTS OFFERED 242

TABLE 202            CONVATEC INC.: DEALS, JANUARY 2021–APRIL 2025        243

TABLE 203            BIO COMPRESSION SYSTEMS, INC.: COMPANY OVERVIEW          244

TABLE 204            BIO COMPRESSION SYSTEMS, INC.: PRODUCTS OFFERED             244

TABLE 205            JUZO GMBH: COMPANY OVERVIEW        245

TABLE 206            JUZO GMBH: PRODUCTS OFFERED         245

TABLE 207            JUZO GMBH: PRODUCT LAUNCHES, JANUARY 2021–APRIL 2025                246

TABLE 208            MEDI GMBH & CO. KG: COMPANY OVERVIEW                 247

TABLE 209            MEDI GMBH & CO. KG: PRODUCTS OFFERED                 247

TABLE 210            PAUL HARTMANN: COMPANY OVERVIEW                 249

TABLE 211            PAUL HARTMANN: PRODUCTS OFFERED                 250

TABLE 212            PAUL HARTMANN: DEALS, JANUARY 2021–APRIL 2025        251

TABLE 213            SANYLEG, S.R.L.: COMPANY OVERVIEW 252

TABLE 214            SANYLEG, S.R.L.: PRODUCTS OFFERED 252

TABLE 215            SIGVARIS GROUP: COMPANY OVERVIEW                 254

TABLE 216            SIGVARIS GROUP: PRODUCTS OFFERED                 254

TABLE 217            SIGVARIS GROUP.: DEALS, JANUARY 2021–APRIL 2025        255

TABLE 218            SMITH+NEPHEW: COMPANY OVERVIEW                 256

TABLE 219            SMITH+NEPHEW: PRODUCTS OFFERED                 257

TABLE 220            SMITH+NEPHEW: EXPANSIONS, JANUARY 2021–APRIL 2025           258

TABLE 221            MEGO AFEK, LTD.: COMPANY OVERVIEW                 259

TABLE 222            MEGO AFEK, LTD.: PRODUCTS OFFERED                 259

TABLE 223            GOTTFRIED MEDICAL, INC.: COMPANY OVERVIEW          261

TABLE 224            THERMOTEK, INC.: COMPANY OVERVIEW                 262

TABLE 225            BAUERFEIND AG: COMPANY OVERVIEW                 263

TABLE 226            OFA BAMBERG GMBH: COMPANY OVERVIEW                 264

TABLE 227            MEDLINE INDUSTRIES: COMPANY OVERVIEW                 265

TABLE 228            ACI MEDICAL: COMPANY OVERVIEW     266

TABLE 229            AIROS MEDICAL INC.: COMPANY OVERVIEW                 267

TABLE 230            BARCELCOM TÊXTEIS, S.A: COMPANY OVERVIEW          268

TABLE 231            CIZETA MEDICALI S.P.A: COMPANY OVERVIEW                 269

TABLE 232            BÖSL MEDIZINTECHNIK: COMPANY OVERVIEW                 270

LIST OF FIGURES

FIGURE 1              COMPRESSION THERAPY MARKET SEGMENTATION & REGIONAL SCOPE    26

FIGURE 2              COMPRESSION THERAPY MARKET: RESEARCH DATA    30

FIGURE 3              COMPRESSION THERAPY MARKET: RESEARCH DESIGN                31

FIGURE 4              RESEARCH METHODOLOGY: HYPOTHESIS BUILDING           36

FIGURE 5              MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION 37

FIGURE 6              COMPRESSION THERAPY MARKET: MARKET SIZE ESTIMATION METHODOLOGY        38

FIGURE 7              MARKET SIZE ESTIMATION: TOP-DOWN APPROACH         39

FIGURE 8              GROWTH PROJECTIONS ON REVENUE IMPACT OF KEY MACROINDICATORS      41

FIGURE 9              DATA TRIANGULATION                42

FIGURE 10            COMPRESSION THERAPY MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION)               44

FIGURE 11            COMPRESSION THERAPY MARKET, BY APPLICATION,

2025 VS. 2030 (USD MILLION)      45

FIGURE 12            COMPRESSION THERAPY MARKET, BY TECHNIQUE, 2025 VS. 2030 (USD MILLION)          46

FIGURE 13            COMPRESSION THERAPY MARKET, BY DISTRIBUTION CHANNEL,

2025 VS. 2030 (USD MILLION)      46

FIGURE 14            COMPRESSION THERAPY MARKET: GEOGRAPHIC OUTLOOK              47

FIGURE 15            GROWING INCIDENCE OF SPORTS INJURIES AND FAVORABLE CLINICAL EVIDENCE TO DRIVE MARKET GROWTH             48

FIGURE 16            ASIA PACIFIC TO BE FASTEST-GROWING MARKET FOR COMPRESSION

THERAPY DURING FORECAST PERIOD  49

FIGURE 17            HOSPITALS & CLINICS AND US WERE LARGEST SEGMENTS IN 2024           50

FIGURE 18            CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD       51

FIGURE 19            COMPRESSION THERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          52

FIGURE 20            GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 VS. 2050       53

FIGURE 21            EUROPE: ROAD DEATHS PER MILLION INHABITANTS, BY COUNTRY, 2021           54

FIGURE 22            REASONS FOR NON-COMPLIANCE WITH COMPRESSION THERAPY             57

FIGURE 23            PORTER’S FIVE FORCES ANALYSIS           60

FIGURE 24            COMPRESSION THERAPY MARKET: ECOSYSTEM ANALYSIS            67

FIGURE 25            COMPRESSION THERAPY MARKET: INVESTMENT & FUNDING SCENARIO,

2019–2023 (USD MILLION)            68

FIGURE 26            NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023              68

FIGURE 27            VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION)            69

FIGURE 28            COMPRESSION THERAPY MARKET: VALUE CHAIN ANALYSIS              72

FIGURE 29            COMPRESSION THERAPY MARKET: SUPPLY CHAIN ANALYSIS              73

FIGURE 30            AVERAGE SELLING PRICE TREND OF COMPRESSION THERAPY PRODUCTS,

BY TYPE, 2022–2024 (USD THOUSAND)   74

FIGURE 31            AVERAGE SELLING PRICE TREND OF COMPRESSION THERAPY MARKET,

BY PRODUCT TYPE, 2022–2024 (USD)      75

FIGURE 32            AVERAGE SELLING PRICE TREND OF COMPRESSION STOCKINGS, BY KEY PLAYER, 2022–2024 (USD THOUSAND)      75

FIGURE 33            AVERAGE SELLING PRICE TREND OF COMPRESSION BRACES, BY KEY PLAYER, 2022–2024 (USD THOUSAND)      76

FIGURE 34            AVERAGE SELLING PRICE TREND OF COMPRESSION THERAPY PRODUCTS,

BY REGION, 2022–2024 (USD THOUSAND)             77

FIGURE 35            COMPRESSION THERAPY MARKET: PATENT ANALYSIS            79

FIGURE 36            COMPRESSION THERAPY MARKET: IMPORT SCENARIO FOR HS CODE 611510, 2020–2024           80

FIGURE 37            COMPRESSION THERAPY MARKET: EXPORT SCENARIO FOR HS CODE 611510, 2020–2024           81

FIGURE 38            TRENDS & DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES           83

FIGURE 39            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF COMPRESSION

THERAPY PRODUCTS    84

FIGURE 40            KEY BUYING CRITERIA FOR TOP THREE END USERS   85

FIGURE 41            NORTH AMERICA: COMPRESSION THERAPY MARKET SNAPSHOT       150

FIGURE 42            ASIA PACIFIC: COMPRESSION THERAPY MARKET SNAPSHOT       171

FIGURE 43            REVENUE ANALYSIS OF TOP FIVE PLAYERS IN COMPRESSION THERAPY MARKET, 2020–2024     199

FIGURE 44            COMPRESSION STOCKINGS MARKET SHARE ANALYSIS, 2024  200

FIGURE 45            COMPRESSION BANDAGES MARKET SHARE ANALYSIS, 2024  200

FIGURE 46            PNEUMATIC COMPRESSION DEVICES MARKET SHARE ANALYSIS, 2024   201

FIGURE 47            COMPRESSION THERAPY MARKET: COMPANY EVALUATION MATRIX

(KEY PLAYERS), 2024       204

FIGURE 48            COMPRESSION THERAPY MARKET: COMPANY FOOTPRINT       205

FIGURE 49            COMPRESSION THERAPY MARKET: COMPANY EVALUATION MATRIX

(START-UPS/SMES), 2024               211

FIGURE 50            EV/EBITDA OF KEY VENDORS   214

FIGURE 51            5-YEAR STOCK BETA OF KEY VENDORS 214

FIGURE 52            BRAND/PRODUCT COMPARATIVE ANALYSIS                 215

FIGURE 53            SOLVENTUM CORPORATION: COMPANY SNAPSHOT (2024)             220

FIGURE 54            ENOVIS CORPORATION: COMPANY SNAPSHOT (2024)    225

FIGURE 55            ESSITY: COMPANY SNAPSHOT (2024)      229

FIGURE 56            CARDINAL HEALTH: COMPANY SNAPSHOT (2024)    233

FIGURE 57            ARJOHUNTLEIGH: COMPANY SNAPSHOT (2024)                 237

FIGURE 58            TACTILE MEDICAL: COMPANY SNAPSHOT (2024)    239

FIGURE 59            CONVATEC INC.: COMPANY SNAPSHOT (2024)                 242

FIGURE 60            PAUL HARTMANN: COMPANY SNAPSHOT (2024)                 250

FIGURE 61            SMITH+NEPHEW: COMPANY SNAPSHOT (2024)                 257

MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• LNGステーション市場 – 2030年までの世界予測 2025-06-16
• アジア太平洋（APAC）ミサイル市場 – 2030年までの地域予測 2025-06-13
• 高圧洗浄機市場 – 2030年までの世界予測 2025-06-12
• 装甲車両市場 – 2030年までの世界予測 2025-06-12
• 工業用ゴム市場 – 2030年までの世界予測 2025-06-12

MarketsandMarkets  出版レポート一覧